← Back to Clinical Trials
Recruiting NCT06658041

NCT06658041 Collaborative Stepped-care Intervention for Adults With Subthreshold Depressive Symptoms in the Primary Care Setting

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06658041
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Depression
Study Type INTERVENTIONAL
Enrollment 352 participants
Start Date 2024-12-23
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 59 Years
Study Type INTERVENTIONAL
Interventions
Cognitive behavioural therapy (CBT)-based intervention with stepped-careCare-as-usual

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 352 participants in total. It began in 2024-12-23 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To ensure accessibility and availability of mental health services in the community and to reduce the burden associated with depression and related conditions, the study aim to evaluate the effectiveness of a collaborative stepped-care intervention (cognitive behavioural therapy-based) for adults with subthreshold depressive symptoms at the district-based primary healthcare setting.

Eligibility Criteria

Inclusion Criteria: * Residing in Hong Kong; * Presenting mild to moderately severe depressive symptoms (PHQ-9 = 5-19); * Able to give informed consent to participate. Exclusion Criteria: * A known history of autism, intellectual disability, schizophrenia-spectrum disorder, bipolar disorder, Parkinson's disease, or dementia; * Imminent suicidal risk; * Difficulty in communication that would limit meaningful participation in psychological intervention.

Contact & Investigator

Central Contact

Stephanie MY Wong, Ph.D.

✉ stephanie@myinwong.com

📞 +85290371111

Principal Investigator

Terry YS Lum, Ph.D.

PRINCIPAL INVESTIGATOR

The University of Hong Kong

Frequently Asked Questions

Who can join the NCT06658041 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 59 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06658041 currently recruiting?

Yes, NCT06658041 is actively recruiting participants. Contact the research team at stephanie@myinwong.com for enrollment information.

Where is the NCT06658041 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06658041 clinical trial?

NCT06658041 is sponsored by The University of Hong Kong. The principal investigator is Terry YS Lum, Ph.D. at The University of Hong Kong. The trial plans to enroll 352 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology